All News #Library
Others
Genmab Announces Financial Results for the First Half of 2024
08 Aug 2024 //
GLOBENEWSWIRE
Genmab Completes Acquisition of ProfoundBio
21 May 2024 //
GLOBENEWSWIRE
Genmab to Broaden & Strengthen Oncology Portfolio with Acq of ProfoundBio
03 Apr 2024 //
BUSINESSWIRE
ProfoundBio to Participate in RBC Capital Markets and JP Morgan Conferences
05 Dec 2023 //
PR NEWSWIRE
ProfoundBio Readies for Next Phase of Growth with Management Team Additions
02 Nov 2023 //
BUSINESSWIRE
ProfoundBio Receives FDA "Study May Proceed" Letter for PRO1184
03 Aug 2022 //
PRNEWSWIRE
ProfoundBio Announces Completion of $70M Series A+ Financing to Advance ADCs
02 Jun 2022 //
PRNEWSWIRE
ProfoundBio to Highlight Programs and Technology at AACR 2022
08 Mar 2022 //
PRNEWSWIRE

Market Place
Sourcing Support